Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF).
O'Jeanson A, Ioannidis K, Nielsen EI, Galani L, Ginosyan A, Paskalis H, Loryan I, Giamarellou H, Friberg LE, Karaiskos I. O'Jeanson A, et al. Among authors: galani l. Int J Antimicrob Agents. 2025 Jan;65(1):107394. doi: 10.1016/j.ijantimicag.2024.107394. Epub 2024 Nov 23. Int J Antimicrob Agents. 2025. PMID: 39581557 Free article.
Antimicrobial Stewardship in the Hospital Setting: A Narrative Review.
Giamarellou H, Galani L, Karavasilis T, Ioannidis K, Karaiskos I. Giamarellou H, et al. Among authors: galani l. Antibiotics (Basel). 2023 Oct 21;12(10):1557. doi: 10.3390/antibiotics12101557. Antibiotics (Basel). 2023. PMID: 37887258 Free PMC article. Review.
In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study.
Galani I, Papoutsaki V, Karaiskos I, Moustakas N, Galani L, Maraki S, Mavromanolaki VE, Legga O, Fountoulis K, Platsouka ED, Giannopoulou P, Papadogeorgaki H, Damala M, Chinou E, Pasxali A, Deliolanis I, Vagiakou H, Petinaki E, Chli A, Vagdatli E, Kazila P, Papaioannou V, Kontopoulou K, Ferke AN, Moraitou E, Antoniadou A, Giamarellou H. Galani I, et al. Among authors: galani l. Eur J Clin Microbiol Infect Dis. 2023 Jul;42(7):843-852. doi: 10.1007/s10096-023-04616-7. Epub 2023 May 3. Eur J Clin Microbiol Infect Dis. 2023. PMID: 37133639 Free PMC article.
Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.
Karaiskos I, Daikos GL, Gkoufa A, Adamis G, Stefos A, Symbardi S, Chrysos G, Filiou E, Basoulis D, Mouloudi E, Galani L, Akinosoglou K, Arvaniti K, Masgala A, Petraki M, Papadimitriou E, Galani I, Poulakou G, Routsi C, Giamarellou H; Hellenic Ceftazidime/Avibactam Registry Study Group. Karaiskos I, et al. Among authors: galani l. J Antimicrob Chemother. 2021 Feb 11;76(3):775-783. doi: 10.1093/jac/dkaa503. J Antimicrob Chemother. 2021. PMID: 33249436
Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment.
Galani I, Karaiskos I, Angelidis E, Papoutsaki V, Galani L, Souli M, Antoniadou A, Giamarellou H. Galani I, et al. Among authors: galani l. Eur J Clin Microbiol Infect Dis. 2021 Jan;40(1):219-224. doi: 10.1007/s10096-020-04000-9. Epub 2020 Jul 30. Eur J Clin Microbiol Infect Dis. 2021. PMID: 32729059
In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece.
Galani I, Papoutsaki V, Karantani I, Karaiskos I, Galani L, Adamou P, Deliolanis I, Kodonaki A, Papadogeorgaki E, Markopoulou M, Maraki S, Damala M, Prifti E, Vagiakou E, Petinaki E, Fountoulis K, Tsiplakou S, Kirikou H, Souli M, Antoniadou A, Giamarellou H. Galani I, et al. Among authors: galani l. J Antimicrob Chemother. 2020 Aug 1;75(8):2164-2172. doi: 10.1093/jac/dkaa160. J Antimicrob Chemother. 2020. PMID: 32449909
32 results